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Autoimmnne  hemolytic  anemia  (1-3),  membranous  glomerulonephritis  (4-9), 
systemic connective-tissue disease (7-10), and malignant lymphoma (11,  12) develop 
in aging NZB/B1 mice. The hemolytic (13)  and the renal (8) diseases can be induced 
(within  a  few weeks and independently)  in young NZB/B1 mice by the  transplanta- 
tion  of syngeneic  adult  spleen  cells.  The malignant  lymphomas,  which  develop  in 
older NZB/B1 mice with already established  hemolytic and  renal diseases  (12),  are 
of  two  histological  types,  reticulum  cell  sarcoma and  pleomorphic malignant  lym- 
phoma  (12).  These  lymphomas are  maintained  in  our  laboratory  by  serial  trans- 
plantation within  the strain NZB/B1  (9). 
In recent years, murine leukemias (and lymphomas) of several varieties have 
been shown to be caused Lj viruses (14--18),  a  circumstance  which  has  led  us 
to  ask  whether  some,  or  all,  of the  immunopathological  disorders  arising  in 
NZB/B1 mice might  also be initiated  by viruses  or other  filtrable  agents  (9). 
Accordingly,  relevant  studies  were  undertaken  of  the  biological  activity  of 
cell-free filtrates  prepared from NZB/B1  malignant  lymphomas; in the  course 
of this  investigation  viruslike particles  were identified  by electron microscopy 
in malignant lymphoid  cells and in nonneoplastic  cells and  tissues  of NZB/B1 
mice. A  brief account of this work follows. 
Methods and Materials 
Animals.--The care and the methods of study of our colony of NZB/B1 mice, which was 
derived  from breeding  stock provided by Dr.  Marianne  Bielschowsky,  are described  else- 
where (6) as are also the cervical lymph node origin and the initial transplantation of reticulum. 
cell sarcoma (hereinafter  also called  malignant lymphoma, 93-line) within this strain  (12). 
We also maintain the CBA/T6 strain of mice and Swiss-Webster albino mice. 
Lymphoma (Cell-Free)  Filtrates.--These  were prepared from subcutaneous tumors obtained 
from NZB/BI mice bearing transplants of malignant lymphoma (12), 93-line. In the finally 
standardized  procedure,  the tumor tissue was obtained and handled  under sterile conditions, 
minced, and ground in a chilled mortar with pestle and sand to provide a 10 to 20°7o suspen- 
sion in pH 7.2 buffered isotonic saline. The suspension was centrifuged  in a  (Servall Super- 
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speed) refrigerated  centrifuge successively at 3900 rag (1800 g) and 4200 m,  xf (2300 g) for 20 
rain each and at 9200 raxr (10,000 g) for 2 rain  to obtain a  "clear" supernatant fluid. The 
supematant fluid was then passed  through sterile  Millipore  filters with rated porosities  of 
0.45 # and on occasion 0.22 #, and shown to be capable of retaining  marker bacteria (Scrratia 
marce,  seozs). Aliquots of the bacteriologically sterile cell-free filtrate were injected  subcutane- 
ously (0.15 to 0.3 ml) and intraperitoneally  (0.25 to 0.5 ml) into preweanling  (2 to 3 wk-old) 
NZB/B1 mice on the day of preparation and were also frozen and stored at -70°C.  Similar 
injections  were given to preweanling CBA/T6 mice and to young adult Swiss-Webster mice. 
Electron Microscopy.--Tissues were fixed either with 1% osmium tetroxide  in phosphate 
buffer at pH 7.4 or with 4% giutaraldehyde  in phosphate buffer followed by postfixation with 
1%  osmium  tetroxide  in  phosphate buffer.  Tissues  were  dehydrated in  ethyl alcohol  and 
propylene oxide and embedded in epoxy mixture containing  El)on 812. Sections were cut with 
diamond knives using the Porter-Blum model I microtome and were picked up on bare copper 
grids. All sections were double-stained  with uranyl acetate and lead acetate. Electron micro- 
graphs were made with a Siemens Elmiskop I  at an initial  magnification of 20,000 or 40,000. 
These plates were enlarged  3 times in the preparation of illustrations. 
RESULTS 
Malignant Lymphoma, 93-Line.--Transplants  of this reticulum  cell sarcoma 
grew locally in the subcutaneous  trochar-inoculation  site, reaching a  dimension 
of 3  to 4  cm within  3  to 4  wk after each of the early passages.  The degree of 
lymphoid hyperplasia and the number of plasma cells, including periodic acid- 
Schiff  positive  Russell-body  types,  in  spleen,  lymph  nodes,  and  thymus  of 
tumor-bearing  mice appeared  to  exceed even that  which  commonly occurs  in 
NZB/B1  mice of comparable  age  (4  to  7  months)  as  they,  and  similarly  the 
tumor-bearing  mice,  undergo  antiglobulin  (Coombs')  test  conversion  and 
develop  other manifestations  of autoimmune  hemolytic  anemia.  Surprisingly, 
the glomerular lesions of focal membranous glomerulonephritis  (6, 8) developed 
in  a  2  month-old  NZB/B1  mouse  which  had  carried  a  tumor  transplant  for 
4  wk  and,  in  addition,  diffuse  membranous  glomerulonephritis  occurred  in  a 
tumor-bearing mouse when only 4 months of age. The structural manifestation 
of membranous glomerulonephritis  in older NZB/BI mice bearing transplanted 
tumors was in general severe and similar to that occurring in NZB/BI mice of 
comparable age but not bearing tumor grafts  (6, 8). 
At  the  eighth  serial  transplantation,  the  malignant  lymphoma  displayed 
more rapid local growth and widespread dissemination,  involving spleen, lymph 
nodes  (of  axilIary,  inguinal,  cervical,  brachial,  intrathoracic,  and mesenteric 
regions),  thymus, liver, kidney,  and even bone marrow at this and subsequent 
passages,  which  were in fact then made at  2  to 3  wk intervals  rather  than  at 
3  to  4  wk  as  previously.  The  blood  leukocyte  count  (Wbc/mm*)  was  5300, 
normal,  as in other  recipients.  The histological  and  cytological  appearance  of 
this reticnlum  cell sarcoma, presently  in the eighteenth  transplant  generation 
within the strain NZB/BI, has not changed from that  of the original primary 
tumor  (12),  except perhaps for more active mitosis. Tumor transplantation  to R.  C.  MJ~LLORS AND C.  Y.  HUANG  1033 
normal mice of the  strain  CBA/T6 and  to  Swiss-Webster mice has  thus  far 
been unsuccessful. 
Lympkoma  (Call-Free) Fittrates.--These  were prepared in the initial experi- 
ment from subcutaneous lymphomas obtained from NZB/B1 mice bearing the 
eleventh  serial  transplant  of  malignant  lymphoma,  93-line.  Aliquots  of  the 
cell-free filtrate were injected subcutaneously (0.15  to 0.3  ml)  and  intraperi- 
toneally (0.25  to 0.5  ml)  into  five young (3-wk-old)  male NZB/B1 mice,  all 
litter-mates.  Tumors  did  not  develop in  the  subcutaneous  inoculation  sites 
TABLE  I 
Laboratory Examinations of Young NZB/B1 Mice at 5 to 7 wk After Receiving 
Inoculations of Lymphoma Cell-Free Filtrate 
Recipient No.  1  2  3  4  5 
Proteinuria 
Direct antiglobulin 
test 
FIematocrit, % 
Reticulocytes, % 
Platelets/mm  3 
Wbe/mm  a 
Serum urea nitrogen: 
rag/lO0 ml 
;erum cholesterol, 
mg/lO0 ml 
~erum proteins, 
g/lOO r~ 
Albumin 
at-globulins 
a2-globulins 
/~-globulins 
%globulins 
++ 
38* 
5 
1,100,000 
7,150 
19 
++ 
48 
23* 
2,500,000 
8,500 
21 
++ 
49 
17" 
2,560,000 
6,500 
25 
+++ 
48 
12" 
1,860,000 
7,500 
23 
159 
5.2 
1.8" 
0.5 
1.0 
0.9 
1.0" 
149 
5.1 
1.7" 
0.3 
1.1 
1.1 
0.9* 
158 
5.3 
1.6* 
0.4 
1.3" 
0.9 
1.0" 
169 
5.1 
1.5* 
0.5 
1.1 
1.0 
1.0" 
++ 
49 
2 
2,360,000 
3,500 
42* 
252* 
5.7 
1.8 s 
0.4 
0.3 
1.0 
1.T 
* More than 2 standard deviations from normal mean. 
during the  period of observation  (5  to  7 wk). Weekly urinalyses  showed no 
departure  from the normal until  the third  week following  inoculation,  when 
significant proteinuria (++)  occurred in three of the five mice. Tests for hema- 
turia were negative throughout the period of observation. 
Complete laboratory examinations were made at 5 to 7 wk after inoculation 
of the cell-free filtrate. Results are given in Table I  where significant changes 
in quantitative determinations, that is, values more than two standard devia- 
tions from the normalmean for healthy NZB/B1 mice of similar age, 8 to 12 wk 
old  (8),  are  indicated  by asterisks.  Significant  proteinuria  (++  to  +++) 
occurred in each recipient within 3 to 5 wk after inoculation of cell-free filtrate. 1034  rP~rUNOPATHOLOGY  OF NZB/BL  MICE 
The  direct  antiglobulin  (Coombs')  tests  remained  negative.  Blood  studies 
revealed low hematocrit per cent in recipient 1 and elevated reticulocytes per 
cent in recipients 2, 3, and 4. A decrease of serum albumin and an increase of 
serum'y-globulins occurred in each recipient.  A decrease in total serum proteins 
and increases in serum urea nitrogen and cholesterol occurred in recipient 5. The 
urinary  and  the serum changes  in  the inoculated mice were similar  in kind 
(proteinuria,  hypoalbuminemia,  hypergammaglobulinemia,  and  exceptionally 
hypercholesterolemia) to those which occur in adult NZB/B1 mice with severe 
renal disease and in young NZB/B1 mice with glomerular lesions induced by 
transplants of syngeneic adult spleen cells (8). Blood leukocyte counts (Wbc/ 
nun  s) in the inoculated mice were normal (3500 to 8500) as were the differential 
counts (lymphocytes, 76 to 82 per cent; mononuclears,  1 to 3 per cent; poly- 
morphonuclears,  13 to 20 per cent; eosinophils, 0 to 7 per cent). 
Autopsies were performed on these five NZB/B1 mice which,  apparently in 
good health, were sacrified  at 8 to 12 wk of age, having received injections of 
cell-free  filtrate  5 to 9 wk previously. Total body weights  were 33 to 38  g; 
spleen,  0.09 to 0.12  g; thymus, 0.04  to 0.09  g;  and  kidneys (both together), 
0.45 to 0.54 g. There was neither gross nor microscopic evidence of tumor at the 
inoculation site or elsewhere. The lymph nodes (cervical,  axillary,  inguinal,  and 
mesenteric) were grossly hyperplastic in each animal,  and' microscopically the 
cellular  increase  was mainly of lymphoid, including  reticular and plasma ceil, 
variety. Renal lesions, characterized in 1/~ sections fixed in Carnoy's solution 
and stained with the periodic acid-methenamine silver technique (19) by mem- 
branous  thickening  and  multiple  nodule  formation  along  the  outer  (sub- 
epithelial)  aspect of the glomerular capillary basement membrane, occurred in 
the kidneys of each recipient of cell-free filtrate. This structural change is the 
earliest,  and  a  practically pathognomonic,  lesion  of membranous glomerulo- 
nephritis  of NZB/B1 mice (8); it does not in association  with significant  pro- 
teinuria and hypoalbuminemia  develop spontaneously at less than 4 months of 
age; and, becoming diffuse (involving  every glomerulus),  it is characteristically 
associated with the functional manifestations of severe renal disease in older 
NZB/B1 mice (8, 9). 
Similar  findings  were obtained on a comparable group of NZB/B1 mice in- 
jected as preweanlings  with another preparation of NZB/B1 lymphoma filtrate. 
On the other hand, significant proteinuria, hypoalbuminemia, and glomerulone- 
phritis  were not observed on examination  of either  six  healthy,  untreated,  2 
month-old NZB/B1 mice or nine  young Swiss-Webster mice and eight young 
CBA/T6 mice injeaed as preweanlings  with NZB/B1 lymphoma filtrate. In all 
these experiments,  the direct antiglobulin (Coombs') tests remained negative. 
Viruslike Particles.--Viruslike particles with close resemblance to the typical 
"C"  type routine oncogenic  virus particles  (25)  were identified by means  of 
electron microscopy in malignant  lymphoma  cells,, not  only in  the primary 
tumor but in transplants of this lymphoma at the first and seventh consecutive R.  C.  MELLORS  AND  C.  Y.  HUANG  1035 
passage, Fig. 1. Similar  viruslike particles were identified  in nonneoplastic cells 
of the kidneys,  Fig.  2,  thymus,  Fig. 3,  and  spleen,  Fig. 4,  of NZB/B1 mice 
bearing this transplantable lymphoma. In the kidneys, viruslike particles were 
most numerous near the basal foldings  of the  distal  convoluted tubules  and 
were also present in the epithelial cells (podocytes) of the glomeruli  and in the 
tubular lumens as well. In the thymus and the spleen,  viruslike particles were 
most abundant in cytoplasmic vesicles within lymphoid and reticular cells and 
were also present in extracellular spaces. 
Structurally similar  viruslike particles  were present in comparable sites in 
the kidneys, Fig. 5, spleen, and thymus of nontumor bearing NZB/B1 mice at 
11 and 15 months of age, the thymus (but not the kidneys) of a healthy 6 wk- 
old NZB/B1 mouse, and the kidneys and spleen,  Fig. 6, of 2- to 3-month-old 
NZB/B1 mice which had been injected with NZB/B1 lymphoma filtrate or had 
received  transplants  of NZB/B1 adult  spleen  cells  (8).  The  typical  mature 
viruslike  particle  in  NZB/B1 mouse tissues,  Fig.  8,  had  a  centrally  located 
electron-opaque nucleoid measuring  approximately 55 m/~ in diameter  and a 
double-limiting membrane with round or oval shape and over-all diameter of 
about 100 m/~. 
It should be emphasized that  the typical viruslike particles were found in 
the tissues of NZB/B1 mice obtained from two sources,  namely, mice received 
from Australia in 1963, reared elsewhere  (6), and kept in our animal quarters 
for only 18 days prior to sacrifice, Fig. 7, and those received from New Zealand 
in  1964 as a  breeding nucleus and maintained  for 6 months  in our NZB/B1 
mouse breeding  room  in  isolation from all  other  laboratory animals.  At  all 
times,  personnel  in this  breeding room wore caps,  gowns,  disposable masks, 
and  gloves,  and  exercised  precautions  against  cross-infections.  Comparable 
viruslike particles were not found in the kidneys and spleen of Swiss-Webster 
and CBA/T6 mice on equivalent search by electron microscopy. 
Further studies of fine structure will be presented at a later date. 
DISCUSSION 
The present study indicated that a filtrable agent separable from NZB/B1 
malignant lymphomas was capable, upon inoculation into preweanling NZB/B1 
mice,  of  inducing  lymphoid  cell  hyperplasia,  hypergammaglobulinemia, 
proteinuria,  hypoalbumineroJa,  and  pathological  changes  (focal  membranous 
glomerulonephritis) of kidneys.-functional and structural changes qualitatively 
similar  to those of "spontaneous"  occurrence in older NZB/B1 mice  (4-10); 
and, moreover, that typical vh~slike particles,  identifiable by electron micros° 
copy,  were  present  in NZB/BI mouse tissues and cells,  including  malignant 
and benign lymphoid cells, epithelial cells of renal glomeruli  and tubules, and 
extracellular sites. To our knowledge,  these observations are the first of their 
kind dealing with NZB/B1 mice. 
While the pathogenesis of the induced renal disease and its relation to the 1036  rMMUNOPATHOLOGY  OF  NZB/BL  MICE 
"spontaneous"  disease  are  not  yet  fully  elucidated,  the  following  possible 
sequence of events can be suggested.  Once a viral infection is established, the 
virus or its products might: have a directly injurious effect on renal glomeruli; 
provide antigenic stimulation of lymphoid cells; induce renal disease by hyper- 
sensitivity mechanisms,  as by the  injurious  meeting of circulating  antibody 
with viral antigens in glomeruli  or by the glomerular localization  of circulating 
viral antigen-antibody complexes;  and might further expand the population of 
lymphoid cells and of cell types susceptible to viral action and transform some 
of these into lymphoid cells with autoaggressive (autolmmune) and neoplastic 
behavior. Conceivably, the virus might also be only a passenger virus persisting 
in a tolerant or an immune host. 
Studies are in progress to determine whether the filtrable agent has oncogenic 
properties  and  to  investigate  its  role  in  the  hemolytic  disease  (1-3)  which 
characterizes NZB/B1 mice. Circulating  and in vivo-localized antibodies with 
specificity for the structurally altered glomeruli  in "spontaneous" renal disease 
of  NZB/B1 mice  have  already  been  described  (6),  and,  conceivably,  these 
immunoglobulins may prove to be at least in part antiviral antibodies. A recent 
paper has described the occurrence  of glomerulonephritis  in AKR mice with 
leukemia produced by the inoculation of Friend or Rauscher virus (22). 
While uniquely successful in their positive aspects, the present experiments 
are not the first reported attempts to uncover a transmissible agent in NZB/B1 
mice. The inoculation of twice frozen and thawed NZB/B1 spleen cell suspen- 
sions failed to induce Coombs' test conversion in young NZB/B1 mice (20); 
and the intraperitoneal injection of cell-free filtrates prepared from the pooled 
lymphoid organs  of 24- to 27-wk-old  NZB/BI mice had  no effect on hybrid 
(C57BL X  C3H/Bi)F~ and C3H/Bi mice (21). 
Genetic studies of the offspring  of reciprocal crosses between NZB/B1 and 
other strains of mice and of back crosses to the parent strain have been made 
in an effort to distinguish between the possible action of a vertically transmitted 
mrus  and  chromosomal  factors  in  the  causation  of  autoimmune  hemolytic 
anemia. While some of the findings  were more in conformity with inheritance 
by a  dominant  autosomal  gene  (23),  the  results  in  other  studies  (24)  were 
equally in accord with the hypothesis that a virus is transmitted vertically by 
sperm as well as ovum of NZB/B1 mice and demonstrably affects only animals 
of a strictly limited range of genotypes. 
We have now to study further the natural mode of transmission of the filtrable 
agent  described  in  the  present  work,  its  strain  specificities,  and  relation  to 
known murine viruses. 
SUMMARY AND  CONCLUSIONS 
A  filtrable  agent  separable  from  transplantable  malignant  lymphomas  of 
NZB/B1 mice was capable, upon inoculation into preweanling NZB/B1 mice, of 
inducing  lymphoid  cell  hyperplasia,  hypergammaglobulinemia,  proteinuria, 
hypoalbuminemia,  and pathological changes  (focal membranous glomerulone- R. C. MELLORS  AND C. Y. HUANG  1037 
phritis) of kidneys--renal functional and structural changes qualitatively simi- 
lar to those of spontaneous occurrence in older NZB/B1 mice. 
Viruslike particles with close resemblance to the typical "C" type murine 
oncogenic virus particles were identified by means of electron microscopy in 
NZB/B1 mouse tissues and cells, including malignant lymphoma cells, benign 
lymphoid cells of thymus and spleen, epithelial cells of renal tubules, and extra- 
cellular sites. 
The  relevance  of  these  observations,  the  first  of  their  kind  dealing  with 
NZB/BI  mice, is discussed in relation to the several immunopathological dis- 
orders which characterize this strain of mice. 
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Addendum.--In a continuation of this work, we have been able to induce in Swiss 
mice features of renal and hemolytic disease, including positive antiglobulin (Coombs' 
tests, by neonatal intraperitoneal inoculation of ultracentrifugally purified cell-free 
filtrates of  splenic  tissue  obtained  from old NZB/B1  mice not having malignant 
lymphoma. 
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EXPLANATION  OF PLATES 
Figs.  1 to 8  are electron micrographs of thin  sections  of NZB/B1 mouse  tissues 
double-stained with uranyl acetate and lead acetate. 
PLATE 97 
FIG.  1.  Portion of malignant lymphoma cell containing  ten viruslike particles in 
the  cytoplasm. Portion of nucleus  is  shown  in upper right corner.  Glutaraldehyde- 
osmium fixation.  ×  60,000. 
FIG. 2. Portion of kidney of lymphoma-bearing mouse. Viruslike particles in basal 
portion of distal convoluted tubule.  Glutaraldehyde-osmium fixation.  ×  60,000. THE JOURNAL  OF EXPERIMENTAL  MEDICINE  VOL.  124  PLATE 97 
(Mellors and Huang: Immunopathology  of NZB/B1 mice) PLATE 98 
FIG. 3. Portion of thymus of lymphoma-bearing mouse. Viruslike particles in cyto- 
plasm and vesicles  of a  reticular cell.  Glutaraldehyde-osmium fixation.  X  60,000. 
FIG. 4. Portion of spleen of lymphoma-bearing  mouse. Viruslike particles in vesicles 
of a lymphoid cell. Glutaraldehyde-osmium  fixation. X 60,000. THE JOURNAL  OF EXPERIMENTAL  MEDICINE  VOL.  124  PLATE 98 
(Mellors and Huang: Immunopathology  of NZB/B1 mice) PLATE 99 
FIG. 5. Portion of kidney of 11 month-old mouse. Four viruslike particles in vesicle 
close  to  basal  foldings  of  distal  convoluted  tubule.  Osmium  tetroxide  fixation. 
X  60,000. 
FIG.  6.  Portion  of  spleen  of  3  month-old  mouse  which  had  been  injected with 
lymphoma filtrate. Viruslike particle in cytoplasm of lymphoid cell. Glutaralde-hyde- 
osmium fixation. X  60,000. 
FIG. 7. Portion of kidney of 5 month-old mouse obtained from Australia. Two virus- 
like particles in basement membrane of proximal convoluted tubule. Osmium tetrox- 
ide fixation.  X  60,000. 
FIG. 8.  Portion of collecting tubule of kidney. Viruslike particle (in small vesicle) 
with a  centrally located electron-opaque nudeoid (~-~55 m# in diameter) and a limit- 
ing membrane (N100 m/z in diameter). Osmium tetroxide fixation. X  120,000. THE  JOURNAL OF EXPERIMENTAL MEDICINE VOL. 124  PLATE 99 
(MeUors and Huang: Immunopathology of NZB/B1 mice) 